{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:55:46Z","timestamp":1785297346780,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.plefa.2023.102542","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T03:52:15Z","timestamp":1674705135000},"page":"102542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-681X","authenticated-orcid":false,"given":"Nathalie E.","family":"Marchand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Gomelskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lasky-Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Tatituri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Costenbader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2023.102542_bib0001","first-page":"1","article-title":"Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study","author":"Soussi","year":"2021","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.plefa.2023.102542_bib0002","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","article-title":"Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985\u20132014","volume":"79","author":"Myasoedova","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.plefa.2023.102542_bib0003","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/acr.23194","article-title":"Association between menopausal factors and the risk of seronegative and seropositive rheumatoid Arthritis: results from the Nurses\u2019 health studies","volume":"69","author":"Bengtsson","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.plefa.2023.102542_bib0004","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.semarthrit.2020.08.002","article-title":"Medicare expenditures for conventional and biologic disease modifying agents commonly used for treatment of rheumatoid arthritis","volume":"50","author":"Dalal","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.plefa.2023.102542_bib0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2217\/BMM.15.40","article-title":"Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women","volume":"9","author":"Arkema","year":"2015","journal-title":"Biomark. Med."},{"key":"10.1016\/j.plefa.2023.102542_bib0006","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/art.24350","article-title":"Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies","volume":"60","author":"Karlson","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.plefa.2023.102542_bib0007","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/EDE.0b013e3181b5f0ce","article-title":"EIRA study group, Dietary fish and fish oil and the risk of rheumatoid arthritis","volume":"20","author":"Rosell","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.plefa.2023.102542_bib0008","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/annrheumdis-2013-203338","article-title":"Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women","volume":"73","author":"Di Giuseppe","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.plefa.2023.102542_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.plefa.2023.102542_bib0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2023.102542_bib0011","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution","volume":"27","author":"Serhan","year":"2015","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.plefa.2023.102542_bib0012","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1568026611109060629","article-title":"Novel anti-inflammatory-Pro-resolving mediators and their Receptors","volume":"11","author":"Serhan","year":"2011","journal-title":"CTMC"},{"key":"10.1016\/j.plefa.2023.102542_bib0013","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from Omega-3 Fatty Acids via Cyclooxygenase 2\u2013Nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plefa.2023.102542_bib0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.plefa.2023.102542_bib0015","doi-asserted-by":"crossref","first-page":"C39","DOI":"10.1152\/ajpcell.00024.2014","article-title":"Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue","volume":"307","author":"Colas","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.plefa.2023.102542_bib0016","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel Docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2023.102542_bib0017","first-page":"60","article-title":"Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1","volume":"1","author":"Liu","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.plefa.2023.102542_bib0018","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2023.102542_bib0019","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.plefa.2023.102542_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242543","article-title":"Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators","volume":"15","author":"Sobrino","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.plefa.2023.102542_bib0041","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fphar.2020.00612","article-title":"Role of resolvins in the inflammatory resolution of neurological diseases","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.plefa.2023.102542_bib0021","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.1780330607","article-title":"Dietary fish oil and olive oil supplementation in patients with Rheumatoid Arthritis clinical and immunologic effects","volume":"33","author":"Kremer","year":"1990","journal-title":"Arthrit. Rheumatism"},{"key":"10.1016\/j.plefa.2023.102542_bib0022","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/art.1780380813","article-title":"Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs clinical and immune correlates","volume":"38","author":"Kremer","year":"1995","journal-title":"Arthrit. Rheumat."},{"key":"10.1016\/j.plefa.2023.102542_bib0023","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/CIRCRESAHA.119.315506","article-title":"Enriched marine oil supplements increase peripheral blood specialized Pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study","volume":"126","author":"Souza","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.plefa.2023.102542_bib0024","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1373\/clinchem.2012.190199","article-title":"Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation","volume":"58","author":"Mas","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.plefa.2023.102542_bib0025","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/jn\/nxac075","article-title":"Enriched marine oil supplement increases specific plasma specialized Pro-resolving mediators in adults with obesity","volume":"152","author":"Al-Shaer","year":"2022","journal-title":"J. Nutr."},{"key":"10.1016\/j.plefa.2023.102542_bib0026","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jss.2019.01.038","article-title":"Fish oil increases specialized pro-resolving lipid mediators in PAD (The OMEGA-PAD II Trial)","volume":"238","author":"Ramirez","year":"2019","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.plefa.2023.102542_bib0027","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.plefa.2023.102542_bib0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1198\/016214504000001907","article-title":"False discovery Rate\u2013adjusted multiple confidence intervals for selected parameters","volume":"100","author":"Benjamini","year":"2005","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.plefa.2023.102542_bib0029","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85922","article-title":"Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis","volume":"1","author":"Norling","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.plefa.2023.102542_bib0030","first-page":"2362","article-title":"Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation","volume":"197","author":"Arnardottir","year":"2016","journal-title":"J.I"},{"key":"10.1016\/j.plefa.2023.102542_bib0031","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12891-018-2381-3","article-title":"Association of fish intake and smoking with risk of rheumatoid arthritis and age of onset: a prospective cohort study","volume":"20","author":"Sparks","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.plefa.2023.102542_bib0032","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/annrheumdis-2016-209154","article-title":"Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis","volume":"76","author":"Gan","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.plefa.2023.102542_bib0033","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/kev266","article-title":"Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study","volume":"55","author":"Gan","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.plefa.2023.102542_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-066452","article-title":"Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial","author":"Hahn","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.plefa.2023.102542_bib0035","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3899\/jrheum.161068","article-title":"Plasma levels of eicosapentaenoic acid are associated with Anti-TNF responsiveness in rheumatoid arthritis and inhibit the etanercept-driven rise in Th17 Cell Differentiation in Vitro","volume":"44","author":"Jeffery","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.plefa.2023.102542_bib0036","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20132011","article-title":"18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload\u2013induced maladaptive cardiac remodeling","volume":"211","author":"Endo","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.plefa.2023.102542_bib0037","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/joim.12871","article-title":"Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation","volume":"286","author":"Serhan","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.plefa.2023.102542_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102219","article-title":"Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation","volume":"164","author":"Lamon-Fava","year":"2021","journal-title":"Prostaglandins, Leukotrienes Essential Fatty Acids"},{"key":"10.1016\/j.plefa.2023.102542_bib0039","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1194\/jlr.M060392","article-title":"Bioactive products formed in humans from fish oils","volume":"56","author":"Skarke","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2023.102542_bib0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.clnu.2012.12.010","article-title":"Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors","volume":"32","author":"Dawczynski","year":"2013","journal-title":"Clin. Nutr."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232782300011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232782300011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:12:34Z","timestamp":1760602354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232782300011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":41,"alternative-id":["S095232782300011X"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2023.102542","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2023.102542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102542"}}